|Centre for Drug Design & Discovery (CD3)||Belgium, Flemish Brabant, Vlaams-Brabant|
|Factor E Ventures||Colorado, Fort Collins, United States|
|Huarong Securities Shanghai Yanggao South Road Sales Department||China, Shanghai|
|Huibo Chengzhang Venture Capital||China, Guangdong, Shenzhen|
|JT Financial Service||Japan, Tokyo|
|Kepventure Pte Ltd||-|
|Long Venture Partners||California, San Francisco, United States|
|New Mountain Capital||New York, New York, United States|
|OCV||California, Los Angeles, United States|
|prominent venture capital||-|
|RPS Ventures||California, Palo Alto, United States|
|Seneca Partners||Birmingham, Michigan, United States|
|Shanghai Xuntian Investment||China, Shanghai|
|Shubei Investment||China, Hangzhou, Zhejiang|
|Startup UCLA Accelerator||California, Los Angeles, United States|
|SX Capital, Inc.||Japan, Minato|
|Victorian Clean Technology Fund||-|
|Zhehua Investment||China, Jiaxing, Zhejiang|
|$700K||17 May 2021||Istanbul, Istanbul, Turkey|
|$425K||06 Jun 2019||Istanbul, Istanbul, Turkey|
|01 Jun 2019||Istanbul, Istanbul, Turkey|
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.